info<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Michael \u00e9s un professional experimentat en l’\u00e0mbit de la transfer\u00e8ncia de tecnologia i capital de risc, connectant amb habilitat la recerca cient\u00edfica amb la innovaci\u00f3 comercial. Michael est\u00e0 assumint el c\u00e0rrec de CEO, despr\u00e9s de demostrar un lideratge exit\u00f3s en el desenvolupament de productes de ter\u00e0pia g\u00e8nica. M\u00e9s info<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[516],"tags":[],"class_list":["post-3232","post","type-post","status-publish","format-standard","hentry","category-noticias-ca"],"acf":[],"yoast_head":"\n
Telomere Therapeutics nomena el Dr. Michael Tadros com a CEO - Invivo Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/invivo.partners\/ca\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Telomere Therapeutics nomena el Dr. Michael Tadros com a CEO - Invivo Partners\" \/>\n<meta property=\"og:description\" content=\"Michael \u00e9s un professional experimentat en l’\u00e0mbit de la transfer\u00e8ncia de tecnologia i capital de risc, connectant amb habilitat la recerca cient\u00edfica amb la innovaci\u00f3 comercial. Michael est\u00e0 assumint el c\u00e0rrec de CEO, despr\u00e9s de demostrar un lideratge exit\u00f3s en el desenvolupament de productes de ter\u00e0pia g\u00e8nica. M\u00e9s info\" \/>\n<meta property=\"og:url\" content=\"https:\/\/invivo.partners\/ca\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Invivo Partners\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-17T08:40:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-17T09:30:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/invivo.partners\/wp-content\/uploads\/2024\/04\/Michael-Tadros-e1713343076221-275x300.jpg\" \/>\n<meta name=\"author\" content=\"Bego\u00f1a Aguirre\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Bego\u00f1a Aguirre\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/invivo.partners\/ca\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/ca\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/\"},\"author\":{\"name\":\"Bego\u00f1a Aguirre\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/1dd96371a3f6bd32a0a04f752b53f1ee\"},\"headline\":\"Telomere Therapeutics nomena el Dr. Michael Tadros com a CEO\",\"datePublished\":\"2024-04-17T08:40:50+00:00\",\"dateModified\":\"2024-04-17T09:30:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/invivo.partners\/ca\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/\"},\"wordCount\":68,\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"articleSection\":[\"Noticias\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/invivo.partners\/ca\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/\",\"url\":\"https:\/\/invivo.partners\/ca\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/\",\"name\":\"Telomere Therapeutics nomena el Dr. Michael Tadros com a CEO - Invivo Partners\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/#website\"},\"datePublished\":\"2024-04-17T08:40:50+00:00\",\"dateModified\":\"2024-04-17T09:30:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/invivo.partners\/ca\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/invivo.partners\/ca\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/invivo.partners\/ca\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/invivo.partners\/ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Telomere Therapeutics nomena el Dr. Michael Tadros com a CEO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/invivo.partners\/#website\",\"url\":\"https:\/\/invivo.partners\/\",\"name\":\"Invivo Capital\",\"description\":\"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.\",\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/invivo.partners\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/invivo.partners\/#organization\",\"name\":\"Invivo Capital\",\"url\":\"https:\/\/invivo.partners\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"contentUrl\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"width\":1200,\"height\":630,\"caption\":\"Invivo Capital\"},\"image\":{\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/1dd96371a3f6bd32a0a04f752b53f1ee\",\"name\":\"Bego\u00f1a Aguirre\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/460068a94be660c8b15fdf3032d7898737605cd317d277a63782d52d9fd88201?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/460068a94be660c8b15fdf3032d7898737605cd317d277a63782d52d9fd88201?s=96&d=mm&r=g\",\"caption\":\"Bego\u00f1a Aguirre\"},\"url\":\"https:\/\/invivo.partners\/ca\/author\/bego\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Telomere Therapeutics nomena el Dr. Michael Tadros com a CEO - Invivo Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/invivo.partners\/ca\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/","og_locale":"ca_ES","og_type":"article","og_title":"Telomere Therapeutics nomena el Dr. Michael Tadros com a CEO - Invivo Partners","og_description":"Michael \u00e9s un professional experimentat en l’\u00e0mbit de la transfer\u00e8ncia de tecnologia i capital de risc, connectant amb habilitat la recerca cient\u00edfica amb la innovaci\u00f3 comercial. Michael est\u00e0 assumint el c\u00e0rrec de CEO, despr\u00e9s de demostrar un lideratge exit\u00f3s en el desenvolupament de productes de ter\u00e0pia g\u00e8nica. M\u00e9s info","og_url":"https:\/\/invivo.partners\/ca\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/","og_site_name":"Invivo Partners","article_published_time":"2024-04-17T08:40:50+00:00","article_modified_time":"2024-04-17T09:30:08+00:00","og_image":[{"url":"https:\/\/invivo.partners\/wp-content\/uploads\/2024\/04\/Michael-Tadros-e1713343076221-275x300.jpg"}],"author":"Bego\u00f1a Aguirre","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"Bego\u00f1a Aguirre","Temps estimat de lectura":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/invivo.partners\/ca\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/#article","isPartOf":{"@id":"https:\/\/invivo.partners\/ca\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/"},"author":{"name":"Bego\u00f1a Aguirre","@id":"https:\/\/invivo.partners\/#\/schema\/person\/1dd96371a3f6bd32a0a04f752b53f1ee"},"headline":"Telomere Therapeutics nomena el Dr. Michael Tadros com a CEO","datePublished":"2024-04-17T08:40:50+00:00","dateModified":"2024-04-17T09:30:08+00:00","mainEntityOfPage":{"@id":"https:\/\/invivo.partners\/ca\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/"},"wordCount":68,"publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"articleSection":["Noticias"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/invivo.partners\/ca\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/","url":"https:\/\/invivo.partners\/ca\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/","name":"Telomere Therapeutics nomena el Dr. Michael Tadros com a CEO - Invivo Partners","isPartOf":{"@id":"https:\/\/invivo.partners\/#website"},"datePublished":"2024-04-17T08:40:50+00:00","dateModified":"2024-04-17T09:30:08+00:00","breadcrumb":{"@id":"https:\/\/invivo.partners\/ca\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/invivo.partners\/ca\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/invivo.partners\/ca\/2024\/04\/17\/telomere-therapeutics-appoints-dr-michael-tadros-chief-executive-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/invivo.partners\/ca\/"},{"@type":"ListItem","position":2,"name":"Telomere Therapeutics nomena el Dr. Michael Tadros com a CEO"}]},{"@type":"WebSite","@id":"https:\/\/invivo.partners\/#website","url":"https:\/\/invivo.partners\/","name":"Invivo Capital","description":"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.","publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/invivo.partners\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/invivo.partners\/#organization","name":"Invivo Capital","url":"https:\/\/invivo.partners\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/","url":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","contentUrl":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","width":1200,"height":630,"caption":"Invivo Capital"},"image":{"@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/invivo.partners\/#\/schema\/person\/1dd96371a3f6bd32a0a04f752b53f1ee","name":"Bego\u00f1a Aguirre","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/invivo.partners\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/460068a94be660c8b15fdf3032d7898737605cd317d277a63782d52d9fd88201?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/460068a94be660c8b15fdf3032d7898737605cd317d277a63782d52d9fd88201?s=96&d=mm&r=g","caption":"Bego\u00f1a Aguirre"},"url":"https:\/\/invivo.partners\/ca\/author\/bego\/"}]}},"_links":{"self":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/posts\/3232","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/comments?post=3232"}],"version-history":[{"count":2,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/posts\/3232\/revisions"}],"predecessor-version":[{"id":3256,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/posts\/3232\/revisions\/3256"}],"wp:attachment":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/media?parent=3232"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/categories?post=3232"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/tags?post=3232"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}![\"\"](\"https:\/\/invivo.partners\/wp-content\/uploads\/2024\/04\/Michael-Tadros-e1713343076221-275x300.jpg\")
<\/p>\n